DOI : 10.1055/s-00000036

Laryngo-Rhino-Otologie

Issue S 02 · Volume 100 · May 2021 DOI: 10.1055/s-011-50823


100 JAHRE DGHNO-KHC: WO KOMMEN WIR HER? WO STEHEN WIR? WO GEHEN WIR HIN?
HNO-Online-Kongress, 12.05 - 16.05.2021

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V., Bonn

Präsident: Prof. Dr. med. Stefan K. Plontke, Halle (Saale)
Abstracts (HTML) Abstracts (PDF) List of Authors
Becker, B; Busch, C-J; Hoffmann, AS; Rieckmann, T; Brenner, N; Betz, C; Jagodzinski, A; Schröder, L; Pawlita, M; Viarisio, D; Waterboer, T: Analysis of Human papillomavirus (HPV) 16 early protein antibodies and follow-up of HPV-16 E6-positive patients in the prospective cohort of the Hamburg City Health Study (HCHS)
Engelhardt, D; Fürst, D; Tsamadou, C; Mytilineos, J; Theodoraki, M-N; Döscher, J; Schuler, P; Brunner, C; Hoffmann, T; Laban, S: Differential HLA-Allele-frequency patterns between patients with head neck cancer (HNSCC) and healthy controls as well as HPV-positive and HPV-negative HNSCC patients
Ezic, J; von Witzleben, A; Fehn, A; Bens, M; Thomas, J; Ammerpohl, O; Kolarova, J; Kestler, H; Kraus, J; Döscher, J; Schuler, P; Greve, J; Marienfeld, R; Barth, T; Möller, P; Kleger, A; Theodoraki, M-N; Brand, M; Brunner, C; Hoffmann, T; Ottensmeier, C; Laban, S: RNA-sequencing reveals an immune “hot” gene expression signature in oropharyngeal squamous cell carcinoma which is upregulated upon decitabine treatment in cell lines
Franzen, A; Färber, M; Strieth, S; Dietrich, D: Cell-free circulating DNA-methylation as biomarker for monitoring adjuvant and palliative immunotherapies
Gehrt, F; Rudhart, SA; Thangavelu, K; Geisthoff, UW; Birk, R; Stuck, BA; Hoch, S: Value of CYFRA 21-1 as a tumor marker in the context of treatment for advanced laryngeal- and hypopharyngeal cancer
Hofmann, L; Brunner, C; Schuler, Patrick J; Lotfi, R; Hoffmann, Thomas K; Laban, S; Theodoraki, M-N: Characterization of circulating exosomes as biomarkers for therapy monitoring in Head and Neck cancer (HNSCC) patients
Kansy, B; Concha-Benavente, F; Moskovitz, J; Moy, J; Chandran, U; Lang, S; Ferris, R: Effects of the PD-1 PD-L1 signaling pathway on the functionality of NK cells in the tumor microenvironment of patients with head and neck cancer
Laban, S; Ezic, J; Bichmann, L; Engelhardt, D; Kestler, HA.; von Witzleben, A; Thomas, J; Mytilineos, J; Fürst, D; Döscher, J; Schuler, PJ.; Brunner, C; Hoffmann, TK.; Rammensee, H-G; Stevanovic, S; Mühlenbruch, L: Tumor-exclusive peptides from shared and individual antigens in the HLA-ligandome of oropharyngeal squamous cell carcinoma
Ludwig, S; Rist, M; Tengler, L; Lammert, A; Jungbauer, F; Theodoraki, M-N; Lang, S; Rotter, N; Jablonska, J: The Expression of Immunoregulatory Proteins on Exosomes in Head and Neck Cancer is dependent on the Tumor Stage
Oberste, M; Riders, A; Abbaspour, B; Kerschke, L; Rudack, C: Risk stratification in HPV-associated oropharyngeal squamous cell carcinoma – development and validation of a new risk stratification system
Priese, J; Hums, A-B; Erler, T; Jansen, L; Dürst, M; Schmitz, M; Stieber, B; Guntinas-Lichius, O: ZNF671 – a promising epigenetic biomarker for improved detection of head and neck cancer by quantitative real time pcr
Riders, A; Oberste, M; Abbaspour, B; Rudack, C: Comparison of patient stratification according to the 7th and 8th edition of the TNM staging system of AJCC / UICC for oropharyngeal cancer (OPSCC) in a patient collective in Münster
Rieckmann, T; Zech, H; Köcher, S; Betz, C; Krug, L; Meyer, F; Kriegs, M; Rothkamm, K: A lack of effectiveness in the ATM-orchestrated DNA damage response contributes to the enhanced radiation sensitivity of HPV-positive HNSCC cell lines
Rudhart, SA; Thangavelu, K; Gehrt, F; Geisthoff, UW; Birk, R; Stuck, BA; Hoch, S: Clinical impact of CYFRA 21-1 as a marker for treatment failure in patients with oropharyngeal cancer and primary radio(chemo)therapy
Schmidl, B; Siegl, M; Winter, C; Boxberg, M; Stögbauer, F; Jira, D; Pickhard, A; Wollenberg, B; Wirth, M: NOTCH1 and the tumor microenvironment of the head and neck squamous cell carcinoma
Theodoraki, M-N; Schuler, P; Laban, S; Brunner, C; Hoffmann, TK.; Whiteside, TL.: CD44v3 as a biomarker of tumor derived exosomes in HNSCC patient’s plasma
von Witzleben, A; Currall, E; Wood, O; Chudley, L; Akinyegun, O; Thomas, J; Bendjama, K; Thomas, GJ.; Friedmann, PS.; King, E; Laban, S; Ottensmeier, CH.: Correlation of HPV16 gene status and gene expression in OPSCC
Wagner, S; Würdemann, N; Langer, C; Klussmann, JP; Wittekindt, C: HPV-incidence and the role of p16INK4a expression in squamous cell carcinomas of the oropharynx
Würdemann, N; Alidousty, C; Siefer, OG.; Schafigh, DG.; Hübbers, CU.; Jain, R; Möllenhoff, K; Silling, S; Wieland, U; Akgül, B; Sharma, SJ.; Büttner, R; Speel, Ernst-Jan M.; Wittekindt, C; Wagner, S; Quaas, A; Drzezga, A; Schlamann, M; Schultheis, AM.; Klußmann, JP.: Detection of cell-free HPV16-DNA in liquid biopsy – A promising biomarker for patients with HPV-related oropharyngeal squamous cell carcinoma
Zech, HB; Betz, CS; Kriegs, M; Köcher, S; Mansour, W; Berger, J; Busch, C-J; Möckelmann, N; Böttcher, A; Rothkamm, K; Petersen, C; Rieckmann, T: Patient derived ex vivo slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive OPSCC
Zioga, E; Lang, S; Ferris, RL.; Kansy, B: The effect of different isolation methods on the number and surface expression of phenotypic markers and checkpoint receptors of tumor-infiltrating lymphocytes.